Text reads "Ascend T1D" with mountains and stars on a blue background
Media Release
Read more
New Study Compares ATG to Teplizumab, Aims to Expand Options to Delay Type 1 Diabetes
September 22, 2026 — Type 1 Diabetes TrialNet (TrialNet), the world’s leading international research network dedicated to type 1 diabetes prevention, has launched the ASCEND T1D Study.
